Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-22

Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Pregabalin (Lyrica) for the Treatment of Nerve Pain [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating pregabalin (Lyrica) for nerve pain (neuralgia) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Neuralgia | Phase 3 | Status: COMPLETED